🇺🇸 FDA
Patent

US 8313772

Compositions for targeted delivery of siRNA

granted A61KA61K31/713A61K47/32

Quick answer

US patent 8313772 (Compositions for targeted delivery of siRNA) held by Arrowhead Madison, Inc. expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Madison, Inc.
Grant date
Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/713, A61K47/32, A61K47/549, A61K47/60